TherapeuticsMD bags FDA approval for hormone therapy
The FDA has nodded hormone therapy of TherapeuticsMD for hot flashes that are associated with menopause. Bijuva is an oral treatment that contains molecularly identical (bio-identical) versions of the hormones estradiol and progesterone for menopausal women with a uterus experiencing moderate-to-severe vasomotor symptoms. It was approved with a warning written on it for cardiovascular disorders, probable dementia as well as breast and endometrial cancer. The drug will be made available next year.
Pfizer and Novartis collaborate to aim NASH
Pfizer declared plans to challenge the untreated fatty liver disease with N...
